Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Come on Earnings also don't forget the most important part...

Apr 12, 2007 12:39PM

Apr 13, 2007 02:40AM
Well, in the end, the OS got reduced a little bit: "On January 12, 2007, 381,214,818 shares of common stock, par value $.00001 per share (the issuer’s only class of voting stock) were outstanding." On the record date March 13th there are 379,668,118 OS. And in the Q3 we will see this number (according to the Proxy): 378,668,118 OS as of Feb 28th. Not that much, but better than the 400mio from the Initial Dutton report - if this continues, we might expect about 200-250mio OS at the end of the patents in 2015...;-)) Good night from Europe
Share
New Message
Please login to post a reply